1. Infection

Infection (感染症)

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

製品番号 製品名 CAS 番号 純度 構造式
  • HY-N13987
    Arylomycin B7 459844-30-5 98%
    Arylomycin B7 is a lipohexapeptide antibiotic against Gram-positive bacteria.
    Arylomycin B7
  • HY-N13988
    Abierixin 100634-16-0 98%
    Abierixin has good anti-coccidial activity and weak antibacterial and ionophore activity.
    Abierixin
  • HY-N13990
    Senfolomycin A 11017-36-0 98%
    Senfolomycin A has the effect of anti-Gram-positive bacteria and mycobacterium, and also has the effect of anti-Staphylococcus aureus resistant to penicillin, Streptomycin, Neomycin, Macrolide antibiotics. Senfolomycin A also has weaker effect of anti-Gram-negative bacteria.
    Senfolomycin A
  • HY-N13991
    Senfolomycin B 11031-56-4 98%
    Senfolomycin B has the effect of anti-Gram-positive bacteria and mycobacterium, and also has the effect of anti-Staphylococcus aureus resistant to penicillin, Streptomycin, Neomycin, Macrolide antibiotics. Senfolomycin A also has weaker effect of anti-Gram-negative bacteria.
    Senfolomycin B
  • HY-N13993
    Aranorosinol A 145147-04-2 98%
    Aranorosinol A is a secondary metabolite with weak antibacterial and antifungal properties.
    Aranorosinol A
  • HY-N13994
    Clavamycin A 103059-93-4 98%
    Clavamycin A has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin A
  • HY-N13995
    Serratamolide 5285-25-6 98%
    Serratamolide is a depsipeptide antibiotic. Serratamolide has anti-Gram-positive bacteria, mycobacteria and fungi activity, but the activity is weak.
    Serratamolide
  • HY-N13996
    Clavamycin B 103080-36-0 98%
    Clavamycin B has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin B
  • HY-N13997
    Clavamycin C 103059-94-5 98%
    Clavamycin C has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin C
  • HY-N13998
    Cephalonic acid 18456-04-7 98%
    Cephalonic acid is a pentaprenyl terpenoid compound that can be isolated from the fermentation broth of Cephaloscorlum caerulens. Cephalonic acid has weak antibacterial activity against Staphylococcus aureus.
    Cephalonic acid
  • HY-N13999
    Clavamycin D 103059-95-6 98%
    Clavamycin D has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin D
  • HY-N14003
    Clavamycin E 103059-96-7 98%
    Clavamycin E is a clavam antibiotic.
    Clavamycin E
  • HY-N14005
    Cephamycin A 34279-78-2 98%
    Cephalomycin A shows weak activity against Gram-positive and negative bacteria.
    Cephamycin A
  • HY-N14007
    Cephamycin B 34279-77-1 98%
    Cephalomycin B showes weak activity against Gram-positive and negative bacteria.
    Cephamycin B
  • HY-N14010
    Cationomycin 80394-65-6 98%
    Cationomycin inhibits the activity of Gram-positive bacteria and mycobacterium, but has no effect on Gram-negative bacteria, yeast and fungi. The feed containing 50-100 ppm Cationomycin could effectively prevent coccidiosis of chicken.
    Cationomycin
  • HY-N14011
    Cedarmycin A 363624-69-5 98%
    Cedarmycin A has activities against Candida, Cryptococcus neoforme and Aspergillus fumigatus, with the MIC values of 12.5-50 μg/mL.
    Cedarmycin A
  • HY-N14012
    Cedarmycin B 363624-70-8 98%
    Cedarmycin B has activities against Candida, Cryptococcus neoforme and Aspergillus fumigatus, with the MIC values of 12.5-50 μg/mL.
    Cedarmycin B
  • HY-N14013
    Chondramide A 172430-60-3 98%
    Chondramide A has anti-candida, Henson yeast, lipids yeast, ball-like yeast and other fungal activities, but has no anti-Gram positive and negative bacteria activities.
    Chondramide A
  • HY-N14015
    Cerexin A 55467-31-7 98%
    Cerexin A has anti-Gram-positive bacterial activity.
    Cerexin A
  • HY-N14018
    Glidobactin A 108351-50-4 98%
    Glidobactin A is an acyl peptide antibiotic. Glidobactin A has activity against Candida, Aspergillus fumigatus and Trichophyton, but it is not effective against Candida albicans M-9 infection in mice.
    Glidobactin A
製品番号 製品名 / Synonyms Application Reactivity